Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation

Balci K. G., Balci M. M., CANPOLAT U., Sen F., Akboga M. K., Suleymanoglu M., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.7, ss.474-481, 2016 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 7
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5152/anatoljcardiol.2015.6334
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.474-481
  • Anahtar Kelimeler: atrial fibrillation, warfarin, apixaban, dabigatran, quality of life, anxiety, HOSPITAL ANXIETY, DEPRESSION, GUIDELINES, MANAGEMENT, VALIDITY, THERAPY, DISEASE, IMPACT
  • Gazi Üniversitesi Adresli: Hayır

Özet

Objective: The aim of this study was to compare health-related quality of life (HRQoL) measures between novel oral anticoagulants (NOACs) and warfarin-treated Turkish patients who had been started on oral anticoagulants (OACs) due to non-valvular atrial fibrillation (AF) and to determine the effects of OACs on patient's emotional status, anxiety and depression.